Human Biospecimen Database > Search

Human Biospecimen Database

Welcome to the Human Biospecimen Database. This Web site contains a searchable database of human biospecimens collected, stored, and distributed by biorepositories in the United States for research use. The purpose of this project is to facilitate research leading to treatments and cures for rare diseases, as well as more common diseases, by improving researchers' access to needed human biospecimens by providing a system that enables them to access information about biorepositories and their collections.

This Web-based, searchable database of biospecimens collected, stored, and distributed by biorepositories for research purposes is the first of its kind and will be extremely useful as a comprehensive reference source of human biospecimens in the United States. The database contains up-to-date information first and foremost for biomedical researchers, but also for other segments of the biomedical research community (e.g., research funding entities, professional societies, patient advocacy groups, research administrators, and the biotechnology and pharmaceutical industries). All interested parties can use the database to identify and obtain resources for basic and translational research as well as drug development in rare diseases, genetics, rare and common cancers, immunology, physiology, and cell biology, among other disciplines. Beyond providing information about the availability of biospecimens, this database also provides information about repositories that collect, store, and distribute biospecimens that will be invaluable to the planning and implementation of biomedical research on rare diseases and orphan drug development.

Please click here to log into the Human Biorepositories Database.

For more information about the Human Biospecimen Database project, please visit the following links.

About the Project
Goals and Objectives
Contact Us
Privacy Policy

* This web site and database was originally developed by RAND Corporation under contract by the Office of Rare Diseases Research at the National Institute of Health.